查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
非甾體抗炎藥市場規模、份額和趨勢分析報告：按適應症（關節炎、偏頭痛、眼科）、給藥途徑、分銷渠道、地區、細分市場、預測 2022-2030
市場調查報告書
商品編碼
1114027

非甾體抗炎藥市場規模、份額和趨勢分析報告：按適應症（關節炎、偏頭痛、眼科）、給藥途徑、分銷渠道、地區、細分市場、預測 2022-2030

Non-steroidal Anti-inflammatory Drugs Market Size, Share & Trends Analysis Report By Disease Indication (Arthritis, Migraine, Ophthalmic Diseases), By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2022 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

非甾體抗炎藥的市場增長和趨勢

Grand View Research, Inc. 的新報告顯示，全球非甾體抗炎藥市場在預測期內將以 5.36% 的複合年增長率增長，到 2030 年將達到 312.9 億美元。預計達到美元。

非甾體抗炎藥是主要用於緩解炎症和疼痛以及降低體溫升高的藥物。用於緩解經痛、頭痛、發燒、關節炎、扭傷、緊張和其他慢性疼痛症狀的非甾體抗炎藥 (NSAID) 的高處方率預計將在預測期內推動市場增長。

由於全球範圍內目標疾病和慢性疼痛的患病率上升以及這些疾病在老年人口中的流行等因素，非甾體抗炎藥市場正在增長。預計將見證機會此外，對 OTC 非甾體抗炎藥的需求增加，以及越來越多地採用非甾體抗炎藥治療頭痛、偏頭痛和月經來潮，預計也將推動預測期內的增長。

此外，關節炎和其他與疼痛相關的疾病日益流行也被認為是支持生長的一個因素。例如，英國、法國和德國的骨關節炎患病率高於歐洲其他地區。身體活動較多的人群中關節炎的患病率較低，並且其患病率似乎隨著年齡的增長而增加。因此，預計關節炎患病率的上升也將有助於預測期內的增長。

主要市場參與者正在採取戰略舉措，例如地域擴張和引入非甾體抗炎藥組合，以增加全球市場份額。此外，越來越多的非處方藥用於疼痛管理和其他炎症性疾病的批准預計將支持預測期內的增長。因此，由於主要參與者採取的各種策略，預計市場將促進增長。

地區政府正在採取積極措施來減輕本國偏頭痛和關節炎等疾病的負擔。例如，美國國立衛生研究院啟動了 HEAL 以加快研究工作，以改善疼痛和炎症性疾病的管理。此外，以患者為中心的結果研究所倡議引入非阿片類藥物治療疼痛的方案。預計這些努力將在預測期內提高增長率。

非甾體抗炎藥市場報告亮點

2021 年，由於全球關節炎的高發率，關節炎部分主導了 NSAIDs 市場

零售藥房佔最大份額，預計在預測期內將保持主導地位

由於疼痛和相關疾病的高患病率、高患病率和老年人口增加等因素，預計亞太地區在預測期內的複合年增長率最高

p>

由於關節炎的高發率、主要市場參與者的存在以及該地區研究活動的增加，北美在 2021 年主導了市場。

內容

第一章調查方法及範圍

  • 市場細分和範圍
  • 調查方法
  • 信息採購
    • 購買的數據庫：
    • GVR 內部數據庫
    • 輔助信息
    • 初步調查
    • 初步調查的內容
  • 信息或數據分析
    • 數據分析模型
  • 市場製定和驗證
  • 型號詳情
    • 商品流向分析
      • 方法 1：商品流通方法
  • 輔助信息列表
  • 縮寫列表
  • 目的

第 2 章執行摘要

  • 市場概覽

第 3 章非甾體抗炎藥市場變量、趨勢和範圍

  • 市場動態
    • 市場驅動因素分析
      • 不斷增長的老年人口
      • 目標疾病的患病率增加
    • 市場約束分析
      • 與 NSAID 相關的副作用
  • 繪製滲透率和增長前景
  • 商業環境分析工具
    • SWOT 分析；按因素（政治和法律、經濟和技術）
    • 波特五力分析
    • 行業分析 - Ansoph 矩陣
  • 價格分析
  • 監管場景

第四章監管與政治力量

  • 主要市場參與者的近期趨勢和影響分析
    • 熱圖分析
  • 公司分類
    • 創新者
    • 市場領導者
  • 供應商情況
    • 主要分銷商和渠道合作夥伴列表
    • 主要客戶
    • 2021 年主要參與者的市場份額分析
  • 上市公司
    • 企業市場分析
      • 市場差異化因素
  • 私人公司
    • 主要初創公司列表
  • 分析重大交易和戰略聯盟
    • 推出新產品
    • 收購
    • 擴展名
    • 許可和合作夥伴關係

第 5 章非甾體抗炎藥市場 - 細分分析，按疾病，2018-2030 年（百萬美元）

  • 2021 年和 2030 年疾病適應症市場份額分析（百萬美元）
  • 細分儀表板
  • 2018-2030 年市場規模和預測，趨勢分析（百萬美元）
    • 關節炎
    • 偏頭痛
    • 眼科疾病
    • 其他

第 6 章非甾體抗炎藥市場 - 細分分析，按給藥途徑，2018-2030 年（百萬美元）

  • 2021 年和 2030 年行政失敗市場份額分析（百萬美元）
  • 細分儀表板
  • 2018-2030 年市場規模和預測、趨勢分析（百萬美元）
    • 口語
    • 主題
    • 其他

第 7 章非甾體抗炎藥市場 - 細分分析，按分銷渠道，2018-2030 年（百萬美元）

  • 2021 年和 2030 年分銷渠道市場份額分析（百萬美元）
  • 細分儀表板
  • 2018-2030 年市場規模和預測、趨勢分析（百萬美元）
    • 醫院藥房
    • 零售藥房
    • 在線藥店

第 8 章非甾體抗炎藥市場細分分析，按地區分列，2018-2030 年（百萬美元）

  • 2021 年和 2030 年區域市場份額分析（百萬美元）
  • 區域市場信息中心
  • 北美
    • 美國
  • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 西班牙
    • 法國
    • 意大利
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳大利亞
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 南非
    • 阿拉伯聯合酋長國
    • 沙特阿拉伯

第 9 章競爭力和供應商格局

  • 參與者的分類
    • 創新者
    • 市場領導者
  • 戰略規劃
    • 該市場參與者選擇的主要策略包括：
      • 推出新產品
      • 獲取
      • 擴展名
      • 合同、合作和夥伴關係
      • 其他（重組、出售、市場滲透）：
  • 戰略框架
    • 2021 年主要參與者的市場份額分析
  • 公司簡介
    • 輝瑞公司
      • 公司簡介
      • 財務表現
      • 產品基準
      • 戰略舉措
    • 拜耳公司
      • 公司簡介
      • 財務表現
      • 產品基準
      • 戰略舉措
    • 葛蘭素史克公司
      • 公司簡介
      • 財務表現
      • 產品基準
      • 戰略舉措
    • 雷迪博士實驗室有限公司
      • 公司簡介
      • 財務表現
      • 產品線
      • 戰略舉措
    • Viatris Inc.
      • 公司簡介
      • 財務表現
      • 產品線
      • 戰略舉措
    • 梯瓦製藥工業有限公司
      • 公司簡介
      • 產品基準
      • 戰略舉措
    • 強生服務公司
      • 公司簡介
      • 財務表現
      • 產品基準
    • 默克公司
      • 公司簡介
      • 財務表現
      • 產品基準
      • 戰略舉措
Product Code: GVR-4-68039-952-5

Non-steroidal Anti-inflammatory Drugs Market Growth & Trends:

The global non-steroidal anti-inflammatory drugs market is expected to reach USD 31.29 billion by 2030, expanding at a CAGR of 5.36% during the forecast period, according to a new report by Grand View Research, Inc. Nonsteroidal anti-inflammatory drugs are drugs that are primarily used to relieve inflammation and pain, as well as to lower elevated body temperature. The high prescription rate of non-steroidal anti-inflammatory drugs (NSAIDs) for relief of symptoms of painful periods, headaches, fever, arthritis, sprains, strains, and other types of chronic pain is expected to drive the market during the forecast period.

The non-steroidal anti-inflammatory drugs market is expected to witness growth opportunities owing to factors such as the rising prevalence of targeted diseases and chronic pain across the globe, coupled with the high prevalence of these diseases in the geriatric population. Moreover, increasing demand for OTC NSAIDs and the rising adoption of NSAIDs for headaches, migraines, and menstrual pain are also expected to boost the growth during the forecast period.

Moreover, the increasing prevalence of arthritis and other pain-related disorders is also expected to support the growth. For instance, the prevalence of osteoarthritis is higher in the UK, France, and Germany compared to other countries in the Europe region. The prevalence of arthritis is seen to be lower in people who are often engaged in physical activities, and its prevalence rises with age. Thus, the rising prevalence of arthritis is also expected to cater to the growth during the forecast period.

Key market players are adopting strategic initiatives such as geographical expansion and the introduction of combination non-steroidal anti-inflammatory drugs to increase their market share across the globe. For instance, Alkem Labs and Dr. Reddy's Laboratories Ltd have launched their non-steroidal anti-inflammatory drugs in the U.S. Moreover, increasing approval of OTC drugs for pain management and other inflammatory diseases is expected to drive growth during the forecast period. Thus, owing to the various strategies adopted by key players, the market is likely to boost its growth.

Governments in various regions are undertaking favorable initiatives to reduce the burden of migraine, arthritis, and other diseases in their countries. For instance, the National Institutes of Health has initiated HEAL to accelerate research activities to improve the management of pain and inflammatory diseases. Moreover, the Patient-Centered Outcomes Research Institute has undertaken initiatives to introduce non-opioid treatment options for pain. Such initiatives are expected to increase growth during the forecast period.

Non-steroidal Anti-inflammatory Drugs Market Report Highlights:

  • In 2021, the arthritis segment dominated the NSAIDs market owing to the higher prevalence of arthritis across the globe
  • The retail pharmacy segment held the largest share and is anticipated to maintain its dominance during the forecast period
  • Asia Pacific region is expected to witness the highest CAGR during the forecast period owing to factors such as the high prevalence of pain and related disorders, the high pool of patients, and a rising geriatric population across the region
  • North America dominated the market in 2021 due to the higher prevalence of arthritis, the presence of leading market players, and increased research activities within the region

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation and Scope
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database:
    • 1.3.2 GVR's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details of Primary Research
  • 1.4 Information or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
      • 1.6.1.1 Approach 1: commodity flow approach
  • 1.7 List of Secondary Sources
  • 1.8 List of Abbreviations
  • 1.9 Objectives
    • 1.9.1 Objective 1
    • 1.9.2 Objective 2
    • 1.9.3 Objective 3
    • 1.9.4 Objective 4

Chapter 2 Executive Summary

  • 2.1 Market Summary

Chapter 3 Non-Steroidal Anti-Inflammatory Drugs Market Variables, Trends & Scope

  • 3.1 Market Dynamics
    • 3.1.1 Market Driver Analysis
      • 3.1.1.1 Increasing Geriatric Population
      • 3.1.1.2 Increasing Prevalence of Targeted Diseases
    • 3.1.2 Market Restraint Analysis
      • 3.1.2.1 Side-effects Associated with NSAIDs
  • 3.2 Penetration and Growth Prospect Mapping
  • 3.3 Business Environment Analysis Tools
    • 3.3.1 SWOT Analysis; By factor (Political & Legal, Economic and Technological)
    • 3.3.2 Porter's Five Forces Analysis
    • 3.3.3 Industry Analysis - Ansoff Matrix
  • 3.4 Pricing Analysis
  • 3.5 Regulatory Scenario

Chapter 4 Regulatory & Political Forces

  • 4.1 Recent Developments & Impact Analysis, by Key Market Participants
    • 4.1.1 Heat map analysis
  • 4.2 Company Categorization
    • 4.2.1 Innovators
    • 4.2.2 Market Leaders
  • 4.3 Vendor Landscape
    • 4.3.1 List of key distributors and channel partners
    • 4.3.2 Key customers
    • 4.3.3 Key company market share analysis, 2021
  • 4.4 Public Companies
    • 4.4.1 Company market position analysis
      • 4.4.1.1 Market Differentiators
  • 4.5 Private Companies
    • 4.5.1 List of key emerging companies
  • 4.6 Major Deals and Strategic Alliances Analysis
    • 4.6.1 New Product Launch
    • 4.6.2 Acquisitions
    • 4.6.3 Expansion
    • 4.6.4 Licensing and Partnerships

Chapter 5 Non-Steroidal Anti-Inflammatory Drugs Market - Segment Analysis, By Disease indication, 2018 - 2030 (USD Million)

  • 5.1 Disease Indication Market Share Analysis, 2021 & 2030 (USD Million)
  • 5.2 Segment Dashboard
  • 5.3 Market Size & Forecasts and Trend Analysis, 2018 - 2030 (USD Million)
    • 5.3.1 Arthritis
      • 5.3.1.1 Arthritis market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.3.2 Migraine
      • 5.3.2.1 Migraine market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.3.3 Ophthalmic Diseases
      • 5.3.3.1 Ophthalmic diseases market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.3.4 Others
      • 5.3.4.1 Other market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 6 Non-Steroidal Anti-Inflammatory Drugs Market - Segment Analysis, By Route of Administration, 2018 - 2030 (USD Million)

  • 6.1 Route of Administration Market Share Analysis, 2021 & 2030 (USD Million)
  • 6.2 Segment Dashboard
  • 6.3 Market Size & Forecasts and Trend Analysis, 2018 to 2030 (USD Million)
    • 6.3.1 Oral
      • 6.3.1.1 Oral market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.3.2 Topical
      • 6.3.2.1 Topical market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.3.3 Others
      • 6.3.3.1 Other market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 7 Non-Steroidal Anti-Inflammatory Drugs Market - Segment Analysis, By Distribution Channel, 2018 - 2030 (USD Million)

  • 7.1 Distribution Channel Market Share Analysis, 2021 & 2030 (USD Million)
  • 7.2 Segment Dashboard
  • 7.3 Market Size & Forecasts and Trend Analysis, 2018 to 2030 (USD Million)
    • 7.3.1 Hospital Pharmacy
      • 7.3.1.1 Hospital pharmacy market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.3.2 Retail Pharmacy
      • 7.3.2.1 Retail pharmacy market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.3.3 Online Pharmacy
      • 7.3.3.1 Online pharmacy market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 8 Non-Steroidal Anti-Inflammatory Drugs Market - Segment Analysis, By Region, 2018 - 2030 (USD Million)

  • 8.1 Regional Market Share Analysis, 2021 & 2030 (USD Million)
  • 8.2 Regional Market Dashboard
  • 8.3 North America
    • 8.3.1 North America market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.3.2 U.S.
      • 8.3.2.1 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.4 Canada
    • 8.4.1. Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.5 Europe
    • 8.5.1 Europe market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.5.2 Germany
      • 8.5.2.1 Germany market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.5.3 UK
      • 8.5.3.1 UK market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.5.4 Spain
      • 8.5.4.1 Spain market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.5.5 France
      • 8.5.5.1 France market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.5.6 Italy
      • 8.5.6.1 Italy market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.6 Asia Pacific
    • 8.6.1 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.6.2 Japan
      • 8.6.2.1 Japan market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.6.3 China
      • 8.6.3.1 China market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.6.4 India
      • 8.6.4.1 India market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.6.5 South Korea
      • 8.6.5.1 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.6.6 Australia
      • 8.6.6.1 Australia market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.7 Latin America
    • 8.7.1 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.7.2 Brazil
      • 8.7.2.1 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.7.3 Mexico
      • 8.7.3.1 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.7.4 Argentina
      • 8.7.4.1 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.8 Middle East & Africa
    • 8.8.1 Middle East & Africa market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.8.2 South Africa
      • 8.8.2.1 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.8.3 UAE
      • 8.8.3.1 UAE market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.8.4 Saudi Arabia
      • 8.8.4.1 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 9 Competitive & Vendor Landscape

  • 9.1 Participant Categorization
    • 9.1.1 Innovators
    • 9.1.2 Market Leaders
  • 9.2 Strategy Mapping
    • 9.2.1 Key Strategies Chosen by Players in this Market Include:
      • 9.2.1.1 Launch of new products
      • 9.2.1.2 Acquisition
      • 9.2.1.3 Expansion
      • 9.2.1.4 Agreements, collaborations, partnerships
      • 9.2.1.5 Others (realignment, divestment, market penetration):
  • 9.3 Strategic Framework
    • 9.3.1 Key Company Market Share Analysis, 2021
  • 9.4 Company Profiles
    • 9.4.1 Pfizer Inc.
      • 9.4.1.1 Company overview
      • 9.4.1.2 Financial performance
      • 9.4.1.3 Product benchmarking
      • 9.4.1.4 Strategic initiatives
    • 9.4.2 Bayer AG
      • 9.4.2.1 Company overview
      • 9.4.2.2 Financial performance
      • 9.4.2.3 Product benchmarking
      • 9.4.2.4 Strategic initiatives
    • 9.4.3 GSK plc
      • 9.4.3.1 Company overview
      • 9.4.3.2 Financial performance
      • 9.4.3.3 Product benchmarking
      • 9.4.3.4 Strategic initiatives
    • 9.4.4 Dr. Reddy's Laboratories Ltd
      • 9.4.4.1 Company overview
      • 9.4.4.2 Financial performance
      • 9.4.4.3 Product pipeline
      • 9.4.4.4 Strategic initiatives
    • 9.4.5 Viatris Inc
      • 9.4.5.1 Company overview
      • 9.4.5.2 Financial performance
      • 9.4.5.3 Product pipeline
      • 9.4.5.4 Strategic initiatives
    • 9.4.6 Teva Pharmaceutical Industries Ltd.
      • 9.4.6.1 Company overview
      • 9.4.6.2 Product benchmarking
      • 9.4.6.3 Strategic initiatives
    • 9.4.7 Johnson and Johnson Services, Inc.
      • 9.4.7.1 Company overview
      • 9.4.7.2 Financial performance
      • 9.4.7.3 Product benchmarking
    • 9.4.8 Merck & Co., Inc.
      • 9.4.8.1 Company overview
      • 9.4.8.2 Financial performance
      • 9.4.8.3 Product benchmarking
      • 9.4.8.4 Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 North America NSAIDs Market, By Country, 2018 - 2030 (USD Million)
  • Table 4 North America NSAIDs Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 5 North America NSAIDs Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 6 U.S. NSAIDs Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 7 U.S. NSAIDs Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 8 Canada NSAIDs Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 9 Canada NSAIDs Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 10 Europe NSAIDs Market, By Country, 2018 - 2030 (USD Million)
  • Table 11 Europe NSAIDs Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 12 Europe NSAIDs Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 13 U.K. NSAIDs Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 14 U.K. NSAIDs Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 15 Germany NSAIDs Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 16 Germany NSAIDs Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 17 France NSAIDs Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 18 France NSAIDs Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 19 Spain NSAIDs Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 20 Spain NSAIDs Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 21 Italy NSAIDs Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 22 Italy NSAIDs Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 23 Asia Pacific NSAIDs Market, By Country, 2018 - 2030 (USD Million)
  • Table 24 Asia Pacific NSAIDs Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 25 Asia Pacific NSAIDs Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 26 Japan NSAIDs Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 27 Japan NSAIDs Market, By Route of Administration 2018 - 2030 (USD Million)
  • Table 28 China NSAIDs Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 29 China NSAIDs Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 30 India NSAIDs Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 31 India NSAIDs Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 32 South Korea NSAIDs Market, By Disease Indication 2018 - 2030 (USD Million)
  • Table 33 South Korea NSAIDs Market, By Route of Administration 2018 - 2030 (USD Million)
  • Table 34 Australia NSAIDs Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 35 Australia NSAIDs Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 36 Latin America NSAIDs Market, By Country, 2018 - 2030 (USD Million)
  • Table 37 Latin America NSAIDs Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 38 Latin America NSAIDs Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 39 Brazil NSAIDs Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 40 Brazil NSAIDs Market, By Route of Administration 2018 - 2030 (USD Million)
  • Table 41 Mexico NSAIDs Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 42 Mexico NSAIDs Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 43 Argentina NSAIDs Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 44 Argentina NSAIDs Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 45 Middle East & Africa NSAIDs Market, By Country, 2018 - 2030 (USD Million)
  • Table 46 Middle East & Africa NSAIDs Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 47 Middle East & Africa NSAIDs Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 48 South Africa NSAIDs Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 49 South Africa NSAIDs Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 50 Saudi Arabia NSAIDs Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 51 Saudi Arabia NSAIDs Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 52 UAE NSAIDs Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 53 UAE NSAIDs Market, By Route of Administration, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 NSAIDs market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 NSAIDs market snapshot
  • Fig. 10 NSAIDs market driver impact
  • Fig. 11 NSAIDs market restraint impact
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 SWOT analysis, by a factor (political & legal, economic, and technological)
  • Fig. 14 Porter's five forces analysis
  • Fig. 15 Ansoff matrix
  • Fig. 16 NSAIDs market: Disease indication outlook and key takeaways
  • Fig. 17 NSAIDs market: Disease indication movement analysis
  • Fig. 18 Disease indication segment dashboard
  • Fig. 19 Arthritis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Migraine market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Ophthalmic diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Other market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 NSAIDs market: Route of administration outlook and key takeaways
  • Fig. 24 NSAIDs market: Route of administration movement analysis
  • Fig. 25 Route of administration segment dashboard
  • Fig. 26 Oral market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Topical market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Other market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 NSAIDs market: Distribution channel outlook and key takeaways
  • Fig. 30 NSAIDs market: Distribution channel movement analysis
  • Fig. 31 Distribution channel segment dashboard
  • Fig. 32 Hospital pharmacy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Retail pharmacy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Online pharmacy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 NSAIDs market: regional outlook and key takeaways
  • Fig. 36 Regional outlook, 2021 & 2030 (USD Million)
  • Fig. 37 Regional market dashboard
  • Fig. 38 North America
  • Fig. 39 North America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 U.S.
  • Fig. 41 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 Canada
  • Fig. 43 Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Europe
  • Fig. 45 Europe market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 Germany
  • Fig. 47 Germany market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 U.K.
  • Fig. 49 U.K. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 50 Spain
  • Fig. 51 Spain market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 France
  • Fig. 53 France market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Italy
  • Fig. 55 Italy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 Asia Pacific
  • Fig. 57 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 58 Japan
  • Fig. 59 Japan market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 60 China
  • Fig. 61 China market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 62 India
  • Fig. 63 India market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 64 South Korea
  • Fig. 65 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 66 Australia
  • Fig. 67 Australia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 68 Latin America
  • Fig. 69 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 70 Brazil
  • Fig. 71 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 72 Mexico
  • Fig. 73 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 74 Argentina
  • Fig. 75 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 76 Middle East & Africa
  • Fig. 77 Middle East & Africa market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 78 South Africa
  • Fig. 79 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 80 UAE
  • Fig. 81 UAE market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 82 Saudi Arabia
  • Fig. 83 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 84 Participant categorization
  • Fig. 85 Strategy mapping
  • Fig. 86 Strategic framework
  • Fig. 87 Company market share analysis